We are live on ! Find out more
BOLD

Audentes Therapeutics, Inc
BOLD

Delisted

BOLD was delisted on the 14th of January, 2020.

Back to rankings

126 hedge funds and large institutions have $913M invested in Audentes Therapeutics, Inc in 2018 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 59 increasing their positions, 28 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

135% more call options, than puts

Call options by funds: $1.05M | Put options by funds: $446K

111% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 28

109% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 11

11% more funds holding

Funds holding: 114 → 126 (+12)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

36% less capital invested

Capital invested by funds: $1.43B → $913M (-$518M)

Holders
126
Holders Change
+12
Holders Change %
+10.53%
% of All Funds
2.81%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
23
Increased
59
Reduced
28
Closed
11
Calls
$1.05M
Puts
$446K
Net Calls
+$600K
Net Calls Change
-$208K

Top Buyers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
+$42.8M
2
PHS
PFM Health Sciences
California
+$37.9M
3
BB
BB Biotech
Switzerland
+$19.9M
4
Millennium Management
Millennium Management
New York
+$15.2M
5
Citadel Advisors
Citadel Advisors
Florida
+$13.5M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$36.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$19.2M
3
Franklin Resources
Franklin Resources
California
-$15.9M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$12.9M
5
AllianceBernstein
AllianceBernstein
Tennessee
-$11.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
51
Wells Fargo
California
$2.89M -$7.59M -294,128 -68%
Macquarie Group
52
Macquarie Group
Australia
$2.77M – – –
UBS Group
53
UBS Group
Switzerland
$2.72M +$3.06M +118,660 +1,344%
CAM
54
Cormorant Asset Management
Massachusetts
$2.6M -$82.6K -3,203 -3%
JP Morgan Chase
55
JP Morgan Chase
New York
$2.58M +$99.8K +3,868 +3%
Citigroup
56
Citigroup
New York
$2.32M +$1.98M +76,789 +240%
KCM
57
Kingdon Capital Management
New York
$2.3M +$2.79M +108,031 New
Axa
58
Axa
France
$2.09M +$540K +20,930 +27%
SIM
59
Spark Investment Management
New York
$1.9M +$1.52M +59,000 +195%
Allianz Asset Management
60
Allianz Asset Management
Germany
$1.69M +$108K +4,191 +6%
TA
61
Teachers Advisors
New York
$1.58M +$219K +8,473 +13%
Assenagon Asset Management
62
Assenagon Asset Management
Luxembourg
$1.54M +$1.86M +72,193 New
TCIM
63
TIAA CREF Investment Management
New York
$1.52M +$89.5K +3,470 +5%
Swiss National Bank
64
Swiss National Bank
Switzerland
$1.36M +$524K +20,300 +47%
California State Teachers Retirement System (CalSTRS)
65
California State Teachers Retirement System (CalSTRS)
California
$1.24M +$218K +8,460 +17%
USAA
66
United Services Automobile Association
Texas
$1.17M -$59.7K -2,315 -4%
TCM
67
Tekla Capital Management
Massachusetts
$1.12M +$357K +13,834 +36%
SSA
68
Schonfeld Strategic Advisors
New York
$1.08M +$1.31M +50,700 New
CS
69
Credit Suisse
Switzerland
$1.08M +$738K +28,614 +131%
RhumbLine Advisers
70
RhumbLine Advisers
Massachusetts
$984K +$429K +16,632 +56%
TI
71
Trexquant Investment
Connecticut
$900K +$1.09M +42,197 New
California Public Employees Retirement System
72
California Public Employees Retirement System
California
$876K -$43.9K -1,700 -4%
Squarepoint
73
Squarepoint
New York
$871K +$260K +10,083 +33%
MWM
74
Mission Wealth Management
California
$751K – – –
Bank of America
75
Bank of America
North Carolina
$744K -$326K -12,629 -27%
1 2
3
4 5

BOLD Hedge Fund Activity: Q4 2018 in Review

126 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Audentes Therapeutics, Inc (BOLD) for Q4 2018, worth a combined $913M — down 36% from $1.43B a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new BOLD positions and 11 closed out — a net gain of 12 holders — while 59 added to existing stakes and 28 trimmed.

The largest buyer was Great Point Partners, opening a new position worth an estimated $42.8M. The largest seller was T. Rowe Price Associates, cutting an estimated $36.7M.

  • 126 institutional investors held Audentes Therapeutics, Inc (BOLD) as of Q4 2018, up from 114 in Q3 2018.
  • Funds reported $913M of Audentes Therapeutics, Inc stock for Q4 2018, down 36% quarter-over-quarter.
  • 23 funds opened new Audentes Therapeutics, Inc positions in Q4 2018 and 11 closed out, a net change of +12 holders.
  • The largest Audentes Therapeutics, Inc buyer in Q4 2018 was Great Point Partners, an estimated $42.8M added.
  • The largest Audentes Therapeutics, Inc seller in Q4 2018 was T. Rowe Price Associates, an estimated $36.7M sold.

Based on aggregated 13F filings for Q4 2018.